Ananth Bioorganics Limited has announced its un-audited financial results for the quarter and half year ended September 30, 2026. The company’s Board of Directors reviewed and approved these results during a meeting held on November 5, 2026. The financial statements, prepared in accordance with Indian Accounting Standards, reflect the company’s performance during the specified periods, including profitability before and after tax, and comprehensive income.
Ananth Bioorganics Announces Q2 FY27 Financials
Ananth Bioorganics Limited (formerly known as Gayatri Bioorganics Limited) has disclosed its un-audited financial results for the quarter and half year ended September 30, 2026. These results were formally approved by the company’s Board of Directors during a meeting convened on November 5, 2026.
Financial Highlights
For the quarter ended September 30, 2026, the company reported a profit after tax of ₹4.87 Lakhs. The total comprehensive income for the same period also stood at ₹4.87 Lakhs. For the half-year ended September 30, 2026, the net profit after tax was ₹4.87 Lakhs, with total comprehensive income mirroring this amount.
In the prior year, for the quarter ended September 30, 2025, the company had reported a net loss after tax of (₹10.17 Lakhs) and a total comprehensive loss of (₹10.17 Lakhs). The half-year ended September 30, 2025, showed a net loss after tax of (₹21.13 Lakhs) and a total comprehensive loss of (₹21.13 Lakhs).
Balance Sheet Overview
As of September 30, 2026, the company’s total assets stood at ₹203.70 Lakhs, compared to ₹171.75 Lakhs as of March 31, 2026. The total equity and liabilities on September 30, 2026, were ₹203.70 Lakhs. Equity share capital remained constant at ₹7,878.81 Lakhs, while other equity was (₹11,584.61 Lakhs), resulting in a net worth of (₹3,705.80 Lakhs).
Cash Flow Statement
The cash flow statement for the period ended September 30, 2026, indicates a net cash used in operating activities of (₹56.39 Lakhs). Cash flow from financing activities resulted in a net inflow of ₹56.91 Lakhs, primarily from borrowings. The net increase in cash and cash equivalents for the period was ₹0.52 Lakhs, bringing the closing balance of cash and cash equivalents to ₹2.52 Lakhs.
Company Name Change
A significant note indicates that during the year, the company’s name was officially changed from GAYATRI BIOORGANICS LIMITED to ANANTH BIOORGANICS LIMITED, effective October 16, 2026, following approval from the Registrar of Companies.
Source: BSE
